Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2, Multicenter, Open-Label, Two-Stage Study to Evaluate the Safety and Efficacy of Intra-Arterial Catheter-Directed Alfimeprase for Restoration of Neurologic Function and Rapid Opening of Arteries in Stroke (CARNEROS-1)

NCT00499902 is registered in ClinicalTrials.gov with ARCA Biopharma, Inc. as lead sponsor.

NCT NCT00499902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00499902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2, Multicenter, Open-Label, Two-Stage Study to Evaluate the Safety and Efficacy of Intra-Arterial Catheter-Directed Alfimeprase for Restoration of Neurologic Function and Rapid Opening of Arteries in Stroke (CARNEROS-1)
Lead sponsor
ARCA Biopharma, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2007
Completion date
May 31, 2008
Enrollment
7 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke